Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Bennaceur

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|May 17, 2005
[Hope and limits in cell therapies]A Bennaceur-Griscelli, W Vainchenker
Bulletin De L'Academie Nationale De Medecine|March 28, 2001
[Hematopoietic stem cells]L Coulombel, C Pondarre, A Bennaceur
Blood|January 12, 2001
Stromal cells retard the differentiation of CD34(+)CD38(low/neg) human primitive progenitors exposed to cytokines independent of their mitotic historyA Bennaceur-Griscelli, C Pondarré, V Schiavon, et al.
Presse Medicale (Paris, France : 1983)|March 12, 1994
[Corynebacterium diphtheriae septicemia causing bone marrow disease]F David, A Delassence, A Bennaceur, et al.
Blood|July 9, 1999
Murine stromal cells counteract the loss of long-term culture-initiating cell potential induced by cytokines in CD34(+)CD38(low/neg) human bone marrow cellsA Bennaceur-Griscelli, C Tourino, B Izac, et al.
British Journal of Haematology|April 7, 1999
Identification of human T-lymphoid progenitor cells in CD34+ CD38low and CD34+ CD38+ subsets of human cord blood and bone marrow cells using NOD-SCID fetal thymus organ culturesC Robin, A Bennaceur-Griscelli, F Louache, et al.
Reproductive Biomedicine Online|December 26, 2009
Characterization of human PGD blastocysts with unbalanced chromosomal translocations and human embryonic stem cell line derivation?N Frydman, O Féraud, C Bas, et al.
Stem Cell Research|November 24, 2016
Generation of an induced pluripotent stem cell line from a patient with chronic myeloid leukemia (CML) resistant to targeted therapiesG Telliam, O Féraud, F Griscelli, et al.
Bulletin Du Cancer|February 16, 2000
[Evolution of cancer markers: from radio-immunology to DNA chips and from surveillance to forecasting]D Bellet, V Lazar, B B de Paillerets, et al.
European Journal of Immunology|June 30, 1998
NK cells differentiated from bone marrow, cord blood and peripheral blood stem cells exhibit similar phenotype and functionsG Carayol, C Robin, J H Bourhis, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|May 17, 2005
[Hope and limits in cell therapies]A Bennaceur-Griscelli, W Vainchenker
Bulletin De L'Academie Nationale De Medecine|March 28, 2001
[Hematopoietic stem cells]L Coulombel, C Pondarre, A Bennaceur
Blood|January 12, 2001
Stromal cells retard the differentiation of CD34(+)CD38(low/neg) human primitive progenitors exposed to cytokines independent of their mitotic historyA Bennaceur-Griscelli, C Pondarré, V Schiavon, et al.
Presse Medicale (Paris, France : 1983)|March 12, 1994
[Corynebacterium diphtheriae septicemia causing bone marrow disease]F David, A Delassence, A Bennaceur, et al.
Blood|July 9, 1999
Murine stromal cells counteract the loss of long-term culture-initiating cell potential induced by cytokines in CD34(+)CD38(low/neg) human bone marrow cellsA Bennaceur-Griscelli, C Tourino, B Izac, et al.
British Journal of Haematology|April 7, 1999
Identification of human T-lymphoid progenitor cells in CD34+ CD38low and CD34+ CD38+ subsets of human cord blood and bone marrow cells using NOD-SCID fetal thymus organ culturesC Robin, A Bennaceur-Griscelli, F Louache, et al.
Reproductive Biomedicine Online|December 26, 2009
Characterization of human PGD blastocysts with unbalanced chromosomal translocations and human embryonic stem cell line derivation?N Frydman, O Féraud, C Bas, et al.
Stem Cell Research|November 24, 2016
Generation of an induced pluripotent stem cell line from a patient with chronic myeloid leukemia (CML) resistant to targeted therapiesG Telliam, O Féraud, F Griscelli, et al.
Bulletin Du Cancer|February 16, 2000
[Evolution of cancer markers: from radio-immunology to DNA chips and from surveillance to forecasting]D Bellet, V Lazar, B B de Paillerets, et al.
European Journal of Immunology|June 30, 1998
NK cells differentiated from bone marrow, cord blood and peripheral blood stem cells exhibit similar phenotype and functionsG Carayol, C Robin, J H Bourhis, et al.
Pageof 3